?Ain Shams University Faculty of Medicine launched today a new program with the participation of Boehringer Ingelheim to train doctors in the diagnosis, treatment and follow-up of heart muscle weakness, which affects 2% globally, and causes the death of 50% of those diagnosed within five years, while the death rate in Egypt reached 29, 38% due to coronary heart disease in 2018, according to World Health Organization statistics.
?For his part, Dr. Mahmoud El-Metini, President of Ain Shams University, explained the importance of scientific and training programs specialized in the treatment of heart failure diseases due to the fact that many patients around the world have been infected, as these programs allow discussing many scientific research and studies related to the latest therapeutic developments on the global scene, including Various diagnostic methods and treatments as part of the university’s role in raising the level of continuing medical education.
?He pointed out that this scientific meeting is a support for all participants to raise the level of training and the level of expertise not only for doctors of the Faculty of Medicine, but also for their peers from outside the university from other hospitals, in a way that supports the process of continuing medical education in various medical fields and the field of cardiology in particular..
?He added that he is pleased that the scientific meeting is taking place within the walls of Ain Shams University in its new dress of advanced lecture halls that match international standards, new scientific conference halls, and other advanced capabilities that the university has witnessed.
?Dr. Ayman Saleh, Vice President of Ain Shams University for Graduate Studies and Research, says that the cardiomyopathy program is part of a system carried out by the university to train workers in all fields, including doctors, nursing and pharmacists..
?With regard to cardiologists, whether for adults, children or internists, and in cooperation with the doctors of the army and police hospitals in Egypt, they will participate in the training system and the advancement of medical professions, as it extends to nursing and pharmacists as part of the health system, and training inside and outside Egypt.
?Regarding his specialization as a cardiologist, Dr. Ayman explained that the reasons for the increase in the spread of the disease in Egypt and the world are due to the increase in the causes leading to it, and included high blood pressure that affects more than a quarter of the Egyptian people over the age of 18 and 8% of these patients only receive treatment, in addition to high blood pressure. The incidence of diabetes, the increase in the incidence of coronary artery disease in Egypt5, and the increase in the average lifespan of the Egyptian person, as there is a relationship between aging and heart disease..
?He stressed that heart failure does not necessarily mean weakness of the heart muscle, but there are other types of heart failure, which is called diastolic heart failure, which means that the heart is not weak, but only its flexibility..
?For his part, Dr. Ashraf Omar, Dean of the Faculty of Medicine, Ain Shams University, explained that the university conference on the weakness of the heart muscle keeps pace with the latest diagnostic and therapeutic methods in heart diseases, noting that the changes are very fast in medicine and must be followed up and pursued, pointing out that the Corona pandemic is one of its best advantages was the availability The opportunity to hold frequent meetings via the Internet, to update information and discuss it with experts in different countries to follow up on opinions and reach the most appropriate treatment methods..
?On the other hand, he explained that the Cardiology Department at Ain Shams Medicine is a pioneering department, given that it is the first to provide cardiac catheterization service, and that it provides its advanced and advanced services 24 hours a day in the presence of senior professors working in private hospitals, where one and a half million patients are received annually..
?For his part, Dr. Nabil Farag, Professor and Head of the Cardiology Department, Faculty of Medicine, Ain Shams University, said that the University’s Cardiology Department is the largest locally and at the level of the Middle East region, in comparison to its human potential with advanced professional competencies in all subspecialties of cardiology. It also includes highly advanced equipment, and thus provides Free treatment services for patients at the expense of the state, of a quality that does not differ from the private sector.
?The Department of Cardiology is primarily concerned with the stages of education, whether for students until their graduation, or for master’s and doctoral studies, in addition to conducting various scientific research, and it starts with student education and we produce doctors with a high level of education, master’s and doctoral students and conduct various research.
?He pointed out that one of the most important educational goals for doctors and students is to conduct conferences and programs within the cardiology department, and scientific exercises within it. From inside Ain Shams University to a number of hospitals that provide health service to the Egyptian heart patient for two days inside the training center at Demerdash Hospital, one of the university’s hospitals, pointing out that the disease of the heart muscle weakness has become receiving great global attention, following a collective observation related to the increase in spending on the disease, as it represents 2% of the world’s population1 which causes a financial burden on the state budget directed to all diseases, and it is spent on drug treatment, and frequent referrals to hospitals for these patients annually, stressing that patients with cardiomyopathy 50% die within 5 years of the disease’s diagnosis2, as He reported that three quarters of patients with cardiomyopathy suffer from a low quality of life due to their inability to carry out normal daily activities6..
?He added that 60% of these patients become depressed due to this difficult quality of life7, and this is what prompted the world to pay attention to patients with weak heart muscle, and to provide various means of advanced medicines and devices to treat this disease in order to return the patient to his normal life, and enable him again to work and produce and improve the quality of life in general, and reduce the incidence of death due to disease.
?He explained that the training program will discuss today the foundations of heart muscle weakness, the diagnosis and treatment of the disease, and progress in treating patients with heart muscle weakness, as well as presenting the modern guidelines that were adopted at the European conference a week ago on the weakness of the heart muscle. There are many researches on the subject, and everything that was done in this program will be discussed, and a large number of doctors in Egypt have attended it through the Internet.
?Dr. Farag said that heart failure is a growing concern in Egypt and affects young people in the region compared to Western countries, where the incidence of coronary heart disease in Egypt, according to the 2018 World Health Organization indicators, is 29.38% 3%, and thus calls for the risk and spread of heart failure. Attention experts in the field to share insights and clinical experience about the latest developments and available treatment options. It was therefore important to strengthen partnerships with multinational organizations and companies such as Boehringer Ingelheim, to lead continuing medical education programs for our healthcare professionals on the latest developments in the management of heart failure.. “
?Ahmed Odeh, Boehringer Ingelheim’s Medical and Regulatory Director for the Levant, Iraq and North East Africa, said that the company’s strong track record in creating solutions to meet patients’ needs makes us committed to serving as scientific partners and sharing our expertise in the management of heart failure with the care community. health. We also share Ain Shams University’s goal of ensuring better outcomes for patients and addressing this important health problem, pointing out that continuing medical education allows professionals to gain insights into new research, scientific evidence, and available healthcare solutions to address the burden of heart failure disease, which unfortunately increasingly affects the Young people too 8. We are also committed to our mission of creating value through innovation, investment in research and development, and educational campaigns
To contribute to a healthy society.
In the presence of Prof. Tarek Youssef, Deputy Director of University Hospitals, Prof. Samia Abda, Deputy Director of Hospitals and Director of Infection Control
Ahmed Odeh, Boehringer Ingelheim’s Medical and Regulatory Director for the Levant, Iraq and North East Africa, said that the company’s strong track record in creating solutions to meet patients’ needs makes us committed to serving as scientific partners and sharing our expertise in heart failure management with the care community. health. We also share Ain Shams University’s goal of ensuring better outcomes for patients and addressing this important health problem, pointing out that continuing medical education allows professionals to gain insights into new research, scientific evidence, and available healthcare solutions to address the burden of heart failure disease, which unfortunately increasingly affects the Young people too 8. We are also committed to our mission of creating value through innovation, investment in research and development, and educational campaigns to contribute to a healthy society.